Beta-adrenergic receptor blockers. Adverse effects and drug interactions.
- 1 March 1988
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 11 (3_pt_2) , II21-9
- https://doi.org/10.1161/01.hyp.11.3_pt_2.ii21
Abstract
Adverse effects of beta-adrenergic receptor blocking drugs can be divided into two categories: 1) those that result from known pharmacological consequences of beta-adrenergic receptor blockade; and 2) other reactions that do not appear to result from beta-adrenergic receptor blockade. Adverse effects of the first type include bronchospasm, heart failure, prolonged hypoglycemia, bradycardia, heart block, intermittent claudication, and Raynaud's phenomenon. Neurological reactions include depression, fatigue, and nightmares. It is not yet proven whether the beta 1-selective adrenergic blockers or those with partial agonist activity reduce the overall frequency of adverse reactions seen with propranolol. Patient age does not appear, in itself, to be associated with more beta-blocker side effects. Side effects of the second category are rare. They include an unusual oculomucocutaneous reaction and the possibility of oncogenesis. There are also many drugs that interact with beta-blockers, which may increase toxicity. Finally, there are specific patient characteristics where one beta-blocker may be more effective and safer than another.Keywords
This publication has 66 references indexed in Scilit:
- Pindolol: A New β-Adrenoceptor Antagonist with Partial Agonist ActivityNew England Journal of Medicine, 1983
- Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Prepared for the Norwegian Multicentre Study Group.Circulation, 1982
- A Long-Term Prevention Study with Oxprenolol in Coronary Heart DiseaseNew England Journal of Medicine, 1982
- Atenolol and Timolol, Two New Systemic β-Adrenoceptor AntagonistsNew England Journal of Medicine, 1982
- Intravenous Beta-Blockade in Coronary Heart DiseaseNew England Journal of Medicine, 1982
- Nadolol: A New β-Adrenoceptor AntagonistNew England Journal of Medicine, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Elevated beta-adrenergic receptor number after chronic propranolol treatmentBiochemical and Biophysical Research Communications, 1977
- Adverse Reactions to ??-Adrenergic Receptor Blocking DrugsDrugs, 1974
- ??-Adrenergic Receptor Blocking Drugs in HypertensionDrugs, 1974